Skip to content
OpenCapital
Get started

AngioDynamics ANGO EBITDA

EBITDA at other companies

TFX
TeleflexTFX
$73.93M-35.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$74.65M+6.2%
ICU Medical logo
ICU MedicalICUI
$63.61M+2.0%
Abbott logo
AbbottABT
——
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
——
Stryker logo
StrykerSYK
——

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%—

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0×0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

−$13.0Mebit+
$5.6MDepreciation Depletion & Amortization
=-$7.36M

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's EBITDA?
AngioDynamics (ANGO) reported EBITDA of -$7.36M in Q4 2025.
How has AngioDynamics's EBITDA changed year-over-year?
AngioDynamics's EBITDA decreased by 101.4% year-over-year, from -$3.66M to -$7.36M.
What is the long-term trend for AngioDynamics's EBITDA?
Over 4 years (2021 to 2025), AngioDynamics's EBITDA has grown at a 10.9% compound annual growth rate (CAGR), from -$9.37M to -$14.15M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.